Skip to main content
Top

Breast Cancer

Issue 2/2022

Content (19 Articles)

Open Access Fluorescence in Situ Hybridization Original Article

6q deletion is frequent but unrelated to patient prognosis in breast cancer

Patrick Lebok, Hannah Bönte, Martina Kluth, Christina Möller-Koop, Isabell Witzel, Linn Wölber, Peter Paluchowski, Christian Wilke, Uwe Heilenkötter, Volkmar Müller, Barbara Schmalfeldt, Ronald Simon, Guido Sauter, Luigi Terracciano, Rainer Horst Krech, Albert von der Assen, Eike Burandt

Breast Cancer Original Article

Defer surgery in operable breast cancer: how long is too long?

Sacha Roberts, Aram Rojas, Giulia DiRaimo, Melanie Orlando, Mahir Gachabayov, Maria Castaldi

Breast Cancer Original Article

The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status

Nanae Horisawa, Yayoi Adachi, Daiki Takatsuka, Kazuki Nozawa, Yuka Endo, Yuri Ozaki, Kayoko Sugino, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki, Hiroji Iwata

Mastectomy Original Article

The safety of performing breast reconstruction during the COVID-19 pandemic

Heather R. Faulkner, Suzanne B. Coopey, Eric C. Liao, Michelle Specht, Barbara L. Smith, Amy S. Colwell

Breast Cancer Original Article

FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population

Bin Li, Xiang Cheng, Ying Zhu, Hao Wan, Zequn Lu, Yimin Cai, Wenhui Li, Pengfei Yi, Li Liu, Jiang Chang, Xiaoping Miao, Jianbo Tian, Rong Zhong

Breast Cancer Original Article

Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line

Nazila Fathi Maroufi, Mohsen Rashidi, Vahid Vahedian, Raheleh Jahanbazi, Sahar Mostafaei, Maryam Akbarzadeh, Hamid Kazemzadeh, Hamid-Reza Nejabati, Alireza Isazadeh, Mohammad-Reza Rashidi, Mohammad Nouri

Breast Cancer Original Article

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3

Barbara Zellinger, Ulrich Bodenhofer, Immanuela A. Engländer, Cornelia Kronberger, Brane Grambozov, Elvis Ruznic, Markus Stana, Josef Karner, Gerd Fastner, Karl Sotlar, Felix Sedlmayer, Franz Zehentmayr

Breast Cancer Original Article

The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women

Nita H. Mukand, Naomi Y. Ko, Nadia A. Nabulsi, Colin C. Hubbard, Brian C.-H. Chiu, Kent F. Hoskins, Gregory S. Calip

Ultrasound Original Article

The value of prognostic ultrasound features of breast cancer in different molecular subtypes with a focus on triple negative disease

Andy Evans, Yee Ting Sim, Brooke Lawson, Jane Macaskill, Lee Jordan, Alastair Thompson

Breast Surgery Original Article

Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy

Marco Bernini, Icro Meattini, Calogero Saieva, Carlotta Becherini, Viola Salvestrini, Luca Visani, Giulia Stocchi, Chiara Bellini, Victoria Lorenzetti, Silvia Sordi, Jacopo Nori, Diego De Benedetto, Isacco Desideri, Simonetta Bianchi, Lorenzo Livi, Lorenzo Orzalesi

Mastectomy Original Article

Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis

Changjun Wang, Yan Lin, Hanjiang Zhu, Yidong Zhou, Feng Mao, Xin Huang, Xingtong Zhou, Xi Cao, Qiang Sun

Open Access Mastectomy Original Article

Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I–III breast cancer patients

L. S. E. van Egdom, K. M. de Ligt, L. de Munck, L. B. Koppert, M. A. M. Mureau, H. A. Rakhorst, S. Siesling

Silicone Original Article

Beneficial effects of transdermal administration of tamoxifen on capsular contracture after breast implantation in murine models

Miki Okazaki, Masako Muguruma, Takako Komiya, Kana Miyahara, Takahiko Kawate, Ai Ueda, Saeko Teraoka, Mariko Asaoka, Eiichi Sato, Hajime Matsumura, Takashi Ishikawa

Breast Cancer Original Article

Consumption of dairy products and odds of breast cancer: an Iranian case–control study

Fatemeh Dashti, Sanaz Soltani, Sanaz Benisi-Kohansal, Leila Azadbakht, Ahmad Esmaillzadeh

Breast Cancer Original Article

Predictive and prognostic significance of BRCAness in HER2-negative breast cancer

Aiko Sueta, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, Yoshitaka Fujiki, Lisa Goto-Yamaguchi, Hirotaka Iwase, Yutaka Yamamoto

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine